Conversely, lack of FGF21 expression increases interleukin-17A (IL-17A) production, insulin resistance, and inflammation by free fatty acid (FFA)-mediated induction of Toll-like 4 (TLR4) signaling in hepatocytes. This evidence concerns the gene IL17A and Insulin resistance.